S'abonner

Neurological involvement in Behçet’s disease: 154 cases from a cohort of 925 patients and a review of the literature - 06/05/08

Doi : RN-11-2006-162-11-0035-3787-101019-200608993 

S Benamour,

T Naji,

FZ Alaoui,

H El Kabli,

S El Aidouni

Voir les affiliations

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Neurological involvement in Behçet’s disease (BD) is well recognised with a prevalence of 5.3 to 30 per cent. The purpose of this retrospective study was to analyse the clinical patterns of neuro-Behçet’s (NB) and to compare them with features of 925 NBs recorded in the literature during the same period.

All patients with NB fulfilled the International Study Group criteria for the diagnosis. Ninety-three patients with headache alone were excluded. Clinical findings were complemented by CSF studies, CT and MRI scanning and angiography.

NB was present in 16.4 per cent of BD patients. The male: female ratio was 4: 3. The mean age of NB patients was 31.76 years; the average age at onset was 29.83 years; and the mean duration was 3.81 years. The clinical features were categorised into 2 major types: those with and without parenchymal involvement. Some patients had mixed features. Ninety four patients (61.03 per cent) presented with parenchymal central nervous system (CNS) involvement. The most common findings were pyramidal signs, cranial nerve palsies, a pseudo-bulbar syndrome and cerebellar signs. Twenty seven patients (17.53 per cent) without parenchymal involvement were divided into: a) those with intracranial hypertension - 24 patients (15.58 percent) - presenting with headache, vomiting and bilateral papilloedema; b) those with cerebral arterial involvement - 3 cases, one with cerebral aneurysms. A mixed pattern was found in 9 patients. Erythema nodosum and vascular involvement were more frequently found with intracranial hypertension than in BD without neurological involvement.

Other clinical features that were reported included a pure meningeal pattern in 15 cases, a pure peripheral neuropathy in 4 cases, isolated cranial nerve palsies in 8 cases, chorea in 1 patient and pseudo-tumor of the cervical cord in another. Six cases of juvenile BD and 1 instance of familial BD were found.

One hundred and thirty three patients were treated (86.36 per cent). The mean duration of treatment was 7.46 months. Corticosteroids, immunosuppressive agents (cyclophosphamide, azathioprine, chlorambucil) and anticoagulants (in intracranial hypertension) were used.

The course of the disease was favourable in only 54.13 per cent of cases and poor in 18.79 percent.

The paper concludes that NB occurrs frequently in men and and is more severe, especially when there is parenchymal involvement. 7 deaths were recorded of which 6 had the parenchymal form of the disease.

19 references.


Plan



© 2006 Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 162 - N° 11

P. 1084-1090 - novembre 2006 Retour au numéro

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.